Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020231713 - AGONISTS OF ROR GAMMAt

Publication Number WO/2020/231713
Publication Date 19.11.2020
International Application No. PCT/US2020/031747
International Filing Date 07.05.2020
IPC
C07D 409/06 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 409/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
Applicants
  • BRISTOL-MYERS SQUIBB COMPANY [US]/[US]
Inventors
  • HARIKRISHNAN, Lalgudi S.
  • KAMAU, Muthoni G.
  • FINK, Brian E.
Agents
  • KORSEN, Elliott
  • BARBIC, Andrej
  • BELLOMY, Gregory R.
  • CHAO, Yuan
  • CLAUSS, Isabelle M.
  • COULTER, Kathryn
  • DELAUNEY, Ashton J.
  • FARQUHARSON-TORRES, Serena
  • GOLIAN, Paul D.
  • GREENBLATT, Gary D.
  • GUO, Z. Angela
  • HADAD, Henry
  • HAI, Bing
  • HAN, Bo
  • JACOBSEN, Barry H.
  • LAUB, Friedrich Bernhard
  • LIU, Hong
  • SUN, Jing G.
  • VANATTEN, Mary K.
  • VOM WEGE, Julia
  • WALSH, Brian J.
Priority Data
62/846,78013.05.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) AGONISTS OF ROR GAMMAt
(FR) AGONISTS DE ROR-GAMMAT
Abstract
(EN)
The present invention is directed to compounds of the formula [INSERT CHEMICAL STRUCTURE HERE}] wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
(FR)
La présente invention concerne des composés de formule [INSERER LA STRUCTURE CHIMIQUE ICI], Tous les substituants étant définis dans la description, ainsi que des compositions pharmaceutiquement acceptables comprenant des composés de l'invention et des procédés d'utilisation desdites compositions dans le traitement de divers troubles.
Latest bibliographic data on file with the International Bureau